Skip to main content
. 2020 Feb 12;10:1648. doi: 10.3389/fphar.2019.01648

Figure 10.

Figure 10

Identification and mapping of drug effects for the drug Flecainide based on optical measurements of the AP and Ca2+ transient of hiPSC-CMs following the same structure as Figure 7.